Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.

Turato C, Vitale A, Fasolato S, Ruvoletto M, Terrin L, Quarta S, Ramirez Morales R, Biasiolo A, Zanus G, Zali N, Tan PS, Hoshida Y, Gatta A, Cillo U, Pontisso P.

Br J Cancer. 2014 May 27;110(11):2708-15. doi: 10.1038/bjc.2014.246. Epub 2014 May 8.

2.

SERPINB3 modulates TGF-beta expression in chronic liver disease.

Turato C, Calabrese F, Biasiolo A, Quarta S, Ruvoletto M, Tono N, Paccagnella D, Fassina G, Merkel C, Harrison TJ, Gatta A, Pontisso P.

Lab Invest. 2010 Jul;90(7):1016-23. doi: 10.1038/labinvest.2010.55. Epub 2010 Mar 8.

3.

The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.

Ji F, Fu SJ, Shen SL, Zhang LJ, Cao QH, Li SQ, Peng BG, Liang LJ, Hua YP.

BMC Cancer. 2015 Mar 11;15:116. doi: 10.1186/s12885-015-1127-y.

4.

Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.

Cannito S, Turato C, Paternostro C, Biasiolo A, Colombatto S, Cambieri I, Quarta S, Novo E, Morello E, Villano G, Fasolato S, Musso T, David E, Tusa I, Rovida E, Autelli R, Smedile A, Cillo U, Pontisso P, Parola M.

Oncotarget. 2015 Feb 10;6(4):2206-21.

5.

Role of SERPINB3 in hepatocellular carcinoma.

Pontisso P.

Ann Hepatol. 2014 Nov-Dec;13(6):722-7. Review.

6.

Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.

Chen J, Liu J, Jin R, Shen J, Liang Y, Ma R, Lin H, Liang X, Yu H, Cai X.

PLoS One. 2014 Nov 17;9(11):e111885. doi: 10.1371/journal.pone.0111885. eCollection 2014.

7.

Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.

Yu B, Yang X, Xu Y, Yao G, Shu H, Lin B, Hood L, Wang H, Yang S, Gu J, Fan J, Qin W.

J Hepatol. 2009 May;50(5):948-57. doi: 10.1016/j.jhep.2008.11.020. Epub 2009 Jan 9.

PMID:
19303159
8.

MicroRNAs and SerpinB3 in hepatocellular carcinoma.

Turato C, Simonato D, Quarta S, Gatta A, Pontisso P.

Life Sci. 2014 Mar 28;100(1):9-17. doi: 10.1016/j.lfs.2014.01.073. Epub 2014 Feb 2. Review.

PMID:
24496037
9.

Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.

Yuan RH, Jeng YM, Hu RH, Lai PL, Lee PH, Cheng CC, Hsu HC.

J Gastrointest Surg. 2011 Feb;15(2):321-9. doi: 10.1007/s11605-010-1373-x.

PMID:
21061181
10.

Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma.

Hyeon J, Ahn S, Lee JJ, Song DH, Park CK.

Dig Dis Sci. 2013 Jul;58(7):1916-22. doi: 10.1007/s10620-013-2609-x. Epub 2013 Mar 2.

PMID:
23456506
11.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
13.

Overexpression of renal tumor antigen is associated with tumor invasion and poor prognosis of hepatocellular carcinoma.

Cha HJ, Kim J, Hong SM, Hong SJ, Park JH, Kim ES, Wang HJ, Choi YJ, Do IG, Joh JW, Kim DS, Choi KY.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S404-11. doi: 10.1245/s10434-011-1856-3. Epub 2011 Jun 30. Erratum in: Ann Surg Oncol. 2011 Dec;18 Suppl 3:S321.

PMID:
21717246
14.

LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.

Yang H, Xiong FX, Lin M, Yang Y, Nie X, Zhou RL.

J Cancer Res Clin Oncol. 2010 Feb;136(2):275-81. doi: 10.1007/s00432-009-0659-4. Epub 2009 Aug 19.

PMID:
19690886
15.

Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.

Ruzzenente A, Capra F, Pachera S, Iacono C, Piccirillo G, Lunardi M, Pistoso S, Valdegamberi A, D'Onofrio M, Guglielmi A.

J Gastrointest Surg. 2009 Jul;13(7):1313-20. doi: 10.1007/s11605-009-0903-x. Epub 2009 May 6.

PMID:
19418103
16.

SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity.

Turato C, Cannito S, Simonato D, Villano G, Morello E, Terrin L, Quarta S, Biasiolo A, Ruvoletto M, Martini A, Fasolato S, Zanus G, Cillo U, Gatta A, Parola M, Pontisso P.

Sci Rep. 2015 Dec 4;5:17701. doi: 10.1038/srep17701.

17.

Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma.

Zhang D, Ma X, Sun W, Cui P, Lu Z.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):3386-94. eCollection 2015.

18.

Hepatic progenitor cells express SerpinB3.

Villano G, Turato C, Quarta S, Ruvoletto M, Ciscato F, Terrin L, Semeraro R, Paternostro C, Parola M, Alvaro D, Bernardi P, Gatta A, Pontisso P.

BMC Cell Biol. 2014 Feb 11;15:5. doi: 10.1186/1471-2121-15-5.

20.

OATP1B3 expression is strongly associated with Wnt/β-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma.

Ueno A, Masugi Y, Yamazaki K, Komuta M, Effendi K, Tanami Y, Tsujikawa H, Tanimoto A, Okuda S, Itano O, Kitagawa Y, Kuribayashi S, Sakamoto M.

J Hepatol. 2014 Nov;61(5):1080-7. doi: 10.1016/j.jhep.2014.06.008. Epub 2014 Jun 16.

PMID:
24946283

Supplemental Content

Support Center